Table 3.
Clinical data of 34 cervical SCC patients who received NACT before surgery (n = 34)
| Patients | Age (year) | Selection date | Clinical stage | NACT efficacy |
|---|---|---|---|---|
| 1 |
45 |
2012.1.27 |
Stage Ib2 |
Effective |
| 2 |
34 |
2012.2.4 |
Stage IIa |
Effective |
| 3 |
36 |
2012.3.12 |
Stage IIb |
Effective |
| 4 |
47 |
2012.4.15 |
Stage Ib2 |
Not effective |
| 5 |
57 |
2012.4.17 |
Stage Ib2 |
Effective |
| 6 |
39 |
2012.5.15 |
Stage IIa |
Effective |
| 7 |
45 |
2012.5.18 |
Stage IIa |
Effective |
| 8 |
42 |
2012.6.3 |
Stage IIb |
Not effective |
| 9 |
32 |
2012.6.17 |
Stage Ib2 |
Effective |
| 10 |
66 |
2012.6.26 |
Stage IIa |
Not effective |
| 11 |
59 |
2012.7.14 |
Stage IIb |
Not effective |
| 12 |
46 |
2012.8.4 |
Stage Ib2 |
Effective |
| 13 |
49 |
2012.8.15 |
Stage IIa |
Not effective |
| 14 |
51 |
2012.8.24 |
Stage Ib2 |
Effective |
| 15 |
35 |
2012.8.29 |
Stage Ib2 |
Effective |
| 16 |
38 |
2012.9.16 |
Stage IIa |
Not effective |
| 17 |
40 |
2012.9.19 |
Stage Ib2 |
Effective |
| 18 |
43 |
2012.10.7 |
Stage IIa |
Effective |
| 19 |
58 |
2012.10.11 |
Stage IIb |
Effective |
| 20 |
63 |
2012.10.17 |
Stage IIa |
Not effective |
| 21 |
53 |
2012.10.19 |
Stage Ib2 |
Effective |
| 22 |
48 |
2012.10.25 |
Stage Ib2 |
Effective |
| 23 |
43 |
2012.10.28 |
Stage IIa |
Effective |
| 24 |
45 |
2012.11.1 |
Stage IIb |
Not effective |
| 25 |
44 |
2012.11.5 |
Stage IIa |
Effective |
| 26 |
61 |
2012.11.16 |
Stage Ib2 |
Not effective |
| 27 |
39 |
2012.11.23 |
Stage IIa |
Effective |
| 28 |
67 |
2012.11.25 |
Stage IIa |
Effective |
| 29 |
56 |
2012.11.30 |
Stage Ib2 |
Effective |
| 30 |
44 |
2012.12.2 |
Stage Ib2 |
Effective |
| 31 |
33 |
2012.12.10 |
Stage IIa |
Not effective |
| 32 |
54 |
2012.12.15 |
Stage Ib2 |
Effective |
| 33 |
57 |
2012.12.19 |
Stage IIa |
Effective |
| 34 | 49 | 2012.12.22 | Stage Ib2 | Effective |
Note: SCC, squamous cell carcinoma. NACT, neoadjuvant chemotherapy.